SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001048477-23-000053
Filing Date
2023-12-05
Accepted
2023-12-05 17:01:22
Documents
3
Period of Report
2023-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1701813669.html 3  
1 FORM 3 wk-form3_1701813669.xml 3 1668
2 EX-24 section16filingspowerofa.htm EX-24 4169
3 section16filingspowerofa001.jpg GRAPHIC 241192
  Complete submission text file 0001048477-23-000053.txt   339456
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO STREET SAN RAFAEL CA 94901
Business Address
Hardy Alexander (Reporting) CIK: 0002001910 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26727 | Film No.: 231467433